Synapse

← ˜Die œPharmazie

Papers in ˜Die œPharmazie

Page 8 · newest first

  1. Prediction of plasma protein binding of cephalosporins using an artificial neural network˜Die œPharmazie · 2007
  2. Assessment of "look-alike" packaging designs related to medication errors using information technology˜Die œPharmazie · 2019
  3. Correlation and in vitro studies on radioactive and nonradioactive albendazole-ß-cyclodextrin complex tablets˜Die œPharmazie · 2011
  4. Evaluation of risk factors for nephrotoxicity associated with high-dose vancomycin in Japanese patients˜Die œPharmazie · 2021
  5. Chronopharmaceutical tablet design for prednisone based on geometry and compression physics independent of excipient influence: a mechanistic approach to controlled release˜Die œPharmazie · 2025
  6. Quantitative evaluation of sparfloxacin binding to urological catheter surfaces˜Die œPharmazie · 2012
  7. Polyphenols in Ammania auriculata : Structures, antioxidative activity and cytotoxicity˜Die œPharmazie · 2014
  8. The use of visible absorption spectra to evaluate different color reactions for the detection of cyclic ureides˜Die œPharmazie · 2007
  9. Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid˜Die œPharmazie · 2007
  10. CYP2C19 681G > A polymorphism and pharmacokinetics of clopidogrel in Chinese healthy volunteers˜Die œPharmazie · 2012
  11. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies˜Die œPharmazie · 2014
  12. One hundred years of the history of pharmacy studies in Turkey˜Die œPharmazie · 2015
  13. A simple HPLC-UV method for the determination of dimenhydrinate and related substances – identification of an unknown impurity˜Die œPharmazie · 2007
  14. Selfish DNA: a pharmaceutical perspective˜Die œPharmazie · 2013
  15. Retrospective analysis of risk factors for liposomal amphotericin B-associated nephrotoxicity˜Die œPharmazie · 2020
  16. Walter Krösche (1882–1957) and the Mannich Reaction˜Die œPharmazie · 2008
  17. The history of cholinesterase inhibitors: who was Moschnin(e)?˜Die œPharmazie · 2008
  18. Comparison of two in vitro methods to evaluate the water resistance of sunscreens˜Die œPharmazie · 2012
  19. Ethnopharmacological information from the botanical correspondence of Berthold Seemann (1825 - 1871) – a pilot study˜Die œPharmazie · 2015
  20. Design and optimization of some collagen-minocycline based hydrogels potentially applicable for the treatment of cutaneous wound infections˜Die œPharmazie · 2011
  21. Monitoring of methylergometrine in human breast milk by solid-phase extraction and high-performance liquid chromatography with fluorimetric detection˜Die œPharmazie · 2012
  22. Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands˜Die œPharmazie · 2015
  23. Studies on development of insoluble drugs as pharmaceutical suspensions by response surface methodology˜Die œPharmazie · 2008
  24. Isoquercitrin provides better bioavailability than quercetin: comparison of quercetin metabolites in body tissue and brain sections after six days administration of isoquercitrin and quercetin˜Die œPharmazie · 2012
  25. Nicorandil protects cardiac microvascular endothelial cells from advanced glycation end products induced cytotoxicity via promoting autophagy˜Die œPharmazie · 2021
  26. Investigation of a fenofibrate-hydroxypropyl-β-cyclodextrin system prepared by a co-grinding method˜Die œPharmazie · 2012
  27. Human-Resource-Development for the future provision of Clinical Pharmaceutical Services˜Die œPharmazie · 2025
  28. Kinetics of decomposition of rabeprazole sodium in aqueous solutions determined by high performance liquid chromatography˜Die œPharmazie · 2007
  29. A multicenter randomized controlled trial in patients with type 2 diabetes mellitus to evaluate an "advanced pharmaceutical care" intervention for the prevention of adverse effects and drug-related problems in a follow-uphome visit (BayPharmCareDiabetesTrail)˜Die œPharmazie · 2025
  30. Clinical Pharmaceutical Services in Bundeswehr Hospitals – A Mixed-methods Analysis˜Die œPharmazie · 2022
  31. The nocebo effect: A reason for patients' non-adherence to generic substitution?˜Die œPharmazie · 2010
  32. Proof-of-concept for a miniaturized shake-flask biopharmaceutical solubility determination by sonic mixing˜Die œPharmazie · 2020
  33. Influence of cosolvents, ionic strength and the method of sample preparation on the solubilization of curcumin by Pluronics and HP-γ-cyclodextrin Studies of curcumin and curcuminoids, XLIV˜Die œPharmazie · 2012
  34. An anti-inflammatory active ingredients in Poriae cutis: Screening based on network pharmacology˜Die œPharmazie · 2024
  35. Stimulation of lysozyme release by selected microbial preparations˜Die œPharmazie · 2012
  36. Isosteviol sodium protects heart embryonic H9c2 cells against oxidative stress by activating Akt/GSK-3β signaling pathway˜Die œPharmazie · 2020
  37. Preparation of novel ionotropically crosslinked beads based on alginate-terephthalic acid composites as potential controlled release matrices˜Die œPharmazie · 2014
  38. A composite of graphene oxide and iron oxide nanoparticles for targeted drug delivery of temozolomide˜Die œPharmazie · 2020
  39. Changes in the conformational structure, microscopic and macroscopic pKas of meloxicam on complexation with natural and modified cyclodextrins˜Die œPharmazie · 2007
  40. Molecular authentication and characterization of the antiherpetic activity of the cyanobacterium Arthrospira fusiformis˜Die œPharmazie · 2010
  41. A LC-MS/MS validated method for determination of azithromycin in human tears and its application to an ocular pharmacokinetic study˜Die œPharmazie · 2020
  42. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions˜Die œPharmazie · 2018
  43. Estrogen-like activities in Vitex species from China determined by a cell based proliferation assay˜Die œPharmazie · 2007
  44. Electrochemical behavior of quinapril and its determination in pharmaceutical formulations by square-wave voltammetry at a mercury electrode˜Die œPharmazie · 2008
  45. Dragendorff's reagent: Historical perspectives and current status of a versatile reagent introduced over 150 years ago at the University of Dorpat, Tartu, Estonia˜Die œPharmazie · 2020
  46. Why are aqueous suspensions of the coarse grades of anhydrous calcium hydrogen phosphate acidic?˜Die œPharmazie · 2010
  47. Drug likeness, targets, molecular docking and ADMET studies for some indolizine derivatives˜Die œPharmazie · 2018
  48. Association Between CYP3A5*3 Polymorphism and Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant Patients Receiving Tacrolimus˜Die œPharmazie · 2022
  49. Synthesis and structure elucidation of 2,3,5,6,7,8-hexahydro1-H-[1,2,4]triazolo[1,2-a]pyridazine-1-thione, 3,3-disubstituted and 2-substituted derivatives and evaluation of their inhibitory activity against inducible nitric oxide synthase˜Die œPharmazie · 2014
  50. Pharmacist Theodor Salzer (1833–1900) and the discovery of bisphosphonates˜Die œPharmazie · 2011